Atlas Trials

Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma

Clinical trial NCT02540161 · COMPLETED

Trial details

NCT number
NCT02540161
Sponsor
Annick Desjardins
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Glioma
Start date
2016-02-01
Primary completion
2019-07-10
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.